Schedule 13D ownership disclosure
Corvus Pharmaceuticals Inc
Security class unavailable · CUSIP: 221015100
Event date: 2021-08-02
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 19.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000947871-21-000874
- Form type
- SC 13D
- Filer
- Corvus Pharmaceuticals, Inc.
- CIK
- CIK 1626971
- Filed
- Aug 04, 2021
- Reporting period
- Aug 02, 2021
- Description
- Schedule 13D beneficial ownership